June 28, 2021 — CentraCare, one of the largest health systems in Minnesota, successfully completed the first structural heart procedure in the world using 4-D hologram technology developed by EchoPixel.Â
If you enjoy this content, please share it with a colleague
June 28, 2021 — Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. entered into a multi-year partnership that leverages the companies' synergies in cardiac artificial intelligence (AI) and data analytics.
June 28, 2021 - A recent analysis found that children and adolescents with multisystem inflammatory syndrome in children (MIS-C) caused by COVID-19 initially treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. The research was part of the Overcoming COVID-19 Study, a nationwide collaboration of physicians at pediatric hospitals and the Centers for Disease Control and Prevention (CDC).Â
June 28, 2021 — The U.S. Food and Drug Administration (FDA) announced June 25 it has added a warning on the Moderna and Pfizer COVID-19 messenger RNA (mRNA) vaccine fact sheets to explain they may cause myocarditis in rare cases as a side effect. The agency said the side effect is very rare and patients generally recover quickly, but it can disportionally affect younger patients in their teens and early 20s.Â
June 25, 2021 – COVID-19 changed everything in healthcare, and a benefit from this pandemic was a surge in innovations in the medical field. One of these is the growth in artificial intelligence (AI) guided medical care.
A small number of patients develop inflammation leading to myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna.
If you enjoy this content, please share it with a colleague
June 24, 2021 — Data captured in American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) registries is similar in quality, depth and granularity when compared to data captured through clinical trials, according to research in JACC: Cardiovascular Interventions.[1] The study that compared data from the DAPT Study to NCDR CathPCI Registry data.Â
Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be thwarted by infection. No matter how skilled a cardiac surgeon or how successful a surgery, when an SSI sets in, patients can find themselves fighting for their lives. While not unique to cardiovascular surgery, post-operative infections have severe repercussions for recovering heart surgery patients.
If you enjoy this content, please share it with a colleague
June 23, 2021 — Findings from a small study detailing the treatment of myocarditis-like symptoms in seven people after receiving a COVID-19 vaccine in the U.S.
If you enjoy this content, please share it with a colleague
June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure.